Voiant - About the company
Voiant is an unfunded company based in United States, founded in 2023. It operates as a Provider of AI-driven clinical trial imaging solutions. Voiant has not raised any funding yet. The company has 75 active competitors, including 12 funded and 1 that has exited. Its top competitors include companies like Lila Sciences, BeaconCure and Fauna Bio.
Key Metrics
Founded Year
2023
Location
Stage
Unfunded
Ranked
9th among 75 active competitors
Employee Count
117 as on Apr 30, 2026
Sign up to download Voiant's company profile
Voiant's funding and investors
Voiant has not raised any funding rounds yet.
Voiant's founders and board of directors
Founder? Claim ProfileVoiant's employee count trend
Voiant has 117 employees as of Apr 26. Here is Voiant's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Voiant's Competitors and alternates
Top competitors of Voiant include Lila Sciences, BeaconCure and Fauna Bio. Here is the list of Top 10 competitors of Voiant, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lila Sciences 2023, Cambridge (United States), Series A | Developer of AI-powered autonomous scientific research platforms | $550M | 59/100 | |
2nd | BeaconCure 2016, Tel Aviv (Israel), Series C | Developer of an AI-enabled statistical analysis platform for biometrics teams | $40.9M | 53/100 | |
3rd | Fauna Bio 2018, Berkeley (United States), Seed | Healthcare association involved in animal genomics | $13.1M | 53/100 | |
4th | Prudentia Sciences 2023, Cambridge (United States), Series A | Provider of AI-powered drug asset diligence and valuation | $27M | 48/100 | |
5th | Gesund AI 2021, Cambridge (United States), Seed | Provider of clinical-grade AI solutions for regulatory compliance | $2M | 44/100 | |
6th | Iomed Health 2016, Spain, Series A | Provider of an AI-based Software for collecting EMR for clinical research | $13.1M | 42/100 | |
7th | Verisian 2023, London (United Kingdom), Seed | Developer of clinical trial analysis solutions using traceability and AI | $1.25M | 40/100 | |
8th | ![]() BGM Group Ltd China, Public | Provider of AI-driven solutions for biopharma and insurance | - | - | 39/100 |
9th | Voiant 2023, United States, Unfunded | Provider of AI-driven clinical trial imaging solutions | - | - | 36/100 |
10th | MiBA 2022, Tampa (United States), Unfunded | Healthcare AI technology company providing data for cancer research, clinical trial matching, pharma utilization, and new drug development | - | - | 36/100 |
Looking for more details on Voiant's competitors? Click here to see the top ones
Voiant's Investments and acquisitions
Voiant has made no investments or acquisitions yet.
Reports related to Voiant
Here is the latest report on Voiant's geography:
News related to Voiant
Media has covered Voiant for 1 event in last 1 year, It was about partnerships.
•
Voiant Partners With Ethical to Deploy State-of-the-Art eAdjudication(R) and eDSMB(R) SoftwareAccess Newswire•Dec 01, 2025•Voiant
•
•
Are you a Founder ?
FAQs about Voiant
Explore our recently published companies
- Q Space Labs - Bengaluru based, 2025 founded, Unfunded company
- Folium Sensing - Chennai based, 2024 founded, Unfunded company
- PrecizionIQ - Faridabad based, 2022 founded, Unfunded company
- Instruo - Kochi based, 2024 founded, Funding Raised company
- Niram Tech Services - Vellore based, 2025 founded, Unfunded company
- Aristoverse - Chennai based, 2024 founded, Unfunded company

